Travere Therapeutics Ownership | Who Owns Travere Therapeutics?
Travere Therapeutics Ownership Summary
Travere Therapeutics is owned by 5.13% institutional investors, 0.70% insiders, and 94.16% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.31% of TVTX shares. Delaware Small Cap Core I is the top mutual fund, with 4.42% of its assets in Travere Therapeutics shares.
TVTX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Travere Therapeutics | 5.13% | 0.70% | 94.16% |
Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 8.02M | 10.31% | $139.68M |
Blackrock | 7.64M | 9.86% | $62.84M |
Armistice capital | 7.36M | 9.46% | $128.18M |
Vanguard group | 6.74M | 8.67% | $117.45M |
Rock springs capital management lp | 4.97M | 6.39% | $86.64M |
Macquarie group | 4.26M | 5.48% | $74.20M |
Janus henderson group | 4.06M | 5.22% | $70.69M |
State street | 3.51M | 4.53% | $28.86M |
Morgan stanley | 3.49M | 4.50% | $28.69M |
Viking global investors lp | 2.90M | 3.73% | $50.55M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Rock springs capital management lp | 4.97M | 3.30% | $86.64M |
Kynam capital management, lp | 1.80M | 2.71% | $32.31M |
Parkman healthcare partners | 1.12M | 2.59% | $19.47M |
Birchview capital, lp | 138.00K | 2.15% | $2.47M |
Exome asset management | 118.02K | 1.88% | $2.11M |
Armistice capital | 7.36M | 1.75% | $128.18M |
Eversept partners, lp | 816.25K | 1.49% | $14.63M |
Knott david m jr | 228.00K | 1.44% | $3.97M |
Emerald advisers | 2.13M | 1.43% | $37.03M |
Emerald mutual fund advisers trust | 1.10M | 1.17% | $19.19M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Janus henderson group | 4.06M | 0.04% | 4.03M |
Viking global investors lp | 2.90M | 0.16% | 2.90M |
Bnp paribas arbitrage, snc | 1.21M | 0.01% | 1.21M |
Fmr | 1.12M | 0.00% | 972.60K |
Jennison associates | 816.40K | 0.01% | 816.40K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 3.51M | 0.00% | -3.10M |
Woodline partners lp | 2.11M | 0.25% | -2.23M |
Finepoint capital lp | - | - | -1.78M |
Balyasny asset management | - | - | -1.29M |
Logos global management lp | - | - | -1.00M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Viking global investors lp | 2.90M | 0.16% | 2.90M | $50.55M |
Bnp paribas arbitrage, snc | 1.21M | 0.01% | 1.21M | $21.07M |
Jennison associates | 816.40K | 0.01% | 816.40K | $14.22M |
Abrdn | 392.00K | 0.01% | 392.00K | $6.83M |
Impax asset management group | 300.00K | 0.02% | 300.00K | $5.23M |
Sold Out
Holder | Change |
---|---|
Toronto dominion bank | -3.00 |
Nelson, van denburg & campbell wealth management group | -14.00 |
Global retirement partners | -19.00 |
Pnc financial services group | -20.00 |
Innealta capital | -28.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 11 | -94.74% | 4,535,953 | -95.23% | 5 | 0.03% | 5 | -96.12% | 3 | -94.12% |
Dec 31, 2024 | 107 | -42.47% | 35,070,340 | -57.58% | 45 | 0.40% | 66 | -30.53% | 23 | -58.93% |
Sep 30, 2024 | 185 | 5.11% | 82,651,760 | -6.09% | 106 | 0.82% | 96 | -6.80% | 54 | 14.89% |
Jun 30, 2024 | 176 | -1.68% | 88,008,878 | 0.38% | 113 | 0.88% | 103 | 10.75% | 47 | -7.84% |
Mar 31, 2024 | 179 | 2.29% | 87,677,449 | 2.46% | 113 | 0.91% | 93 | 3.33% | 51 | -5.56% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Delaware Small Cap Core I | 3.45M | 4.42% | -21.39K |
Macquarie Small Cap Core I | 3.56M | 4.01% | 111.60K |
Vanguard Total Stock Mkt Idx Inv | 2.85M | 3.21% | 94.34K |
Aviva Investors GlConvtAbsRet I USD Acc | 2.20M | 2.88% | -229.35K |
Vanguard US Total Market Shares ETF | 2.51M | 2.82% | - |
iShares Russell 2000 ETF | 2.16M | 2.43% | 1.06K |
SPDR® S&P Biotech ETF | 1.64M | 1.84% | 2.12K |
HBM Healthcare Investments AG Ord | 1.32M | 1.48% | -309.55K |
Janus Henderson Global Life Sciences D | 1.25M | 1.41% | 335.59K |
Janus Henderson Global Life Sciences | 1.25M | 1.41% | 701.24K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 05, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | $37.55K |
May 05, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | $398.35K |
May 05, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | Sell | $37.28K |
May 05, 2025 | ROTE WILLIAM E. | Chief Research Officer | Sell | $67.32K |
May 05, 2025 | REED ELIZABETH E | Chief Legal Officer and GC | Sell | $103.57K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 6 |
2025 Q1 | - | 26 |
2024 Q4 | - | 4 |
2024 Q3 | - | 9 |
2024 Q2 | - | 1 |
TVTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools